Skip to main content

MSD enters licensing pact with five Indian generic firms to manufacture, distribute COVID-19 antiviral drug molnupiravir

MSD enters licensing pact with five Indian generic firms to manufacture, distribute COVID-19 antiviral drug molnupiravir Under the agreements, MSD will provide licences to these manufacturers to supply molnupiravir to India and more than 100 LMICs. MSD is also in discussions with the Medicines Patent Pool to explore the potential for additional licences.

from Moneycontrol Business News https://ift.tt/2S1U12h
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

Infosys partners Avaloq to strengthen wealth management capabilities via digital platforms

Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn
Post a Comment
Read more